CME Information: CIDP
Case–Based Approach to the Differential Diagnosis, Treatment, and Long–Term Follow–up of CIDP
At the conclusion of this activity, participants will be able to:
- Formulate a differential diagnosis for a patient who exhibits signs and symptoms of CIDP
- Comparatively assess the safety and efficacy of first-line treatment options for CIDP
- Recognize clinical and neurophysiological parameters of treatment outcomes that indicate stability, improvement, or disease progression
- Identify when and how to modify therapy over the course of the disease
This activity is supported by educational grants from CSL Behring LLC and Grifols.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
Live Internet Activity
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Release/Expiration
Thursday, May 31, 2018 from 12:00pm – 1:00pm EDT.
The enduring material will be available from May 31, 2018 to July 11, 2019.
This activity is intended for US-based neurologists, immunologists, internal medicine physicians, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing, patients with immune-mediated neuropathies.
Method Of Participation
There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Roy Freeman, MD, MB, ChB
Professor of Neurology
Harvard Medical School
Director, Center for Autonomic and Peripheral Nerve Disorders
Beth Israel Deaconess Medical Center
Richard J. Barohn, MD
Gertrude and Dewey Ziegler Professor of Neurology
University Distinguished Professor
Vice Chancellor for Research
President of the Research Institute
University of Kansas Medical Center
Jonathan Katz, MD
Forbes Norris Center for Neuromuscular Disorders
Adjunct Professor of Neurology
Kansas University School of Medicine
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Reported Financial Relationship
- Roy Freeman, MD, MB, ChB
- Richard J. Barohn, MD
Consluting Fees: NuFactor
Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Option Care, Plan 365 Inc.
Contracted Research: Alexion, ALSA, BioMarin, Cytokinetics, Eli Lilly, FDA/OOPD, Ionis, Neuraltus, NIH, Novartis, PTC Therapeutics, Sanofi/Genzyme, Sarepta, Teva
- Jonathan Katz, MD
Consulting Fees: Alexion, MTP, Grifols, CLS
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Anne Roc, PhD
PlatformQ Health Education, LLC
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
DISCLOSURE OF UNAPPROVED/OFF LABEL USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Please contact the Postgraduate Institute for Medicine at www.pimed.com.
For any technical issues or issues with your CME Certificate, please contact NeuroCareLive at 877-394-1306 or at Support@NeuroCareLive.com.